{site_meta && site_meta.display_name} Logo

NewMediaWire

NewMediaWire distributes press releases on behalf of hundreds of publicly traded companies, as well as private corporations, non-profits and other public sector organizations. Founded and staffed by industry veterans, we offer a full complement of services including specialized delivery to financial sites and posting of photos and multimedia content. In addition, NewMediawire offers international and specialized services such as IR websites and industry specific distribution.

RSS Feed for NewMediaWire

LR Health & Beauty SE Publishes Final 2025 Annual Report and Continues to Execute Its Strategic Initiatives

August 4, 2026 Preliminary FY 2025 sales and EBITDA confirmed Solid financial footing provides scope to consistently advance strategic initiatives aimed at optimizing production, logistics and sales AHLEN, GERMANY - August 4, 2026 (NEWMEDIAWIRE) - LR Health & Beauty SE, Europe’s leading social commerce company for high-quality nutritional supplements and beauty products, has today published its final annual report for 2025. The sales and earnings figures for the 2025 financial year, as communicated in the preliminary results, are thereby confirmed: for the full 2025 year, the LR Group generated sales (revenue from goods sold) of EUR 277.


Katrin Neuffer to Head Investor & Public Relations at Medios AG

August 4, 2026BERLIN - August 4, 2026 (NEWMEDIAWIRE) - Medios AG (“Medios”), a leading provider of Specialty Pharma in Europe, has appointed Katrin Neuffer (49) as Director Investor Relations & Communications, effective immediately. In this role, she will be responsible for the Company’s communications with investors, analysts, the media, and the public.


SRX Global (SRXH) Acquires Stake in Vistagen Therapeutics

August 4, 2026LOS ANGELES, CA - August 4, 2026 (NEWMEDIAWIRE) - SRX Global (NYSE American: SRXH) announced that it has acquired a stake in Vistagen Therapeutics, a late clinical-stage biopharmaceutical company developing intranasal neuroscience therapies based on its proprietary pherine platform. SRX said the investment aligns with its strategy of creating long-term shareholder value through investments in high-conviction operating companies and strategic assets.


Western Star Resources Accelerates U.S. Tungsten Strategy With Three Past-Producing Assets, 2026 Drilling Plans and Pathway Toward Maiden Mineral Resource at Eagle Point

August 4, 2026VANCOUVER, BRITISH COLOMBIA - August 4, 2026 (NEWMEDIAWIRE) - Western Star Resources Inc. (CSE: WSR) (OTC: WSRIF) (FRA: 4K2) (the “Company” or “Western Star”) is pleased to provide a corporate and exploration update following a significant period of growth, during which the Company assembled and began advancing a portfolio of past-producing tungsten assets in the United States.


Nordex Group Obtains 77 MW Order in Romania

August 3, 2026HAMBURG, GERMANY - August 3, 2026 (NEWMEDIAWIRE) - The Nordex Group has received an order from the Swedish renewable energy company OX2 for the supply and installation of 11 N175/6. X turbines in Romania.


Partners Group Drives EBITDA Margin Uplift Through AI Collaboration Between Private Equity Portfolio Companies

August 3, 2026 The 120 bps uplift was generated at US insurance broker Foundation Risk Partners and represents USD 10 million of financial impact The AI program was delivered by UK digital transformation specialist Version 1 and led to a significant fall in policy processing times at FRP The collaboration demonstrates how transformational AI value creation can be driven through private equity portfolio partnerships DENVER - August 3, 2026 (NEWMEDIAWIRE) - Partners Group, one of the largest firms in the global private markets industry, has driven a 120 bps EBITDA margin uplift at portfolio company Foundation Risk Partners ("FRP"), one of the fastest-growing insurance brokerages in the US, through an AI transformation program. The program was delivered in collaboration with Version 1, another Partners Group portfolio company and a leader in AI-first digital transformation services.


Regentis Biomaterials (RGNT) Advances Regenerative Solution for Major Unmet Need in Cartilage Repair

August 3, 2026LOS ANGELES, CA - August 3, 2026 (NEWMEDIAWIRE) - Regentis Biomaterials (NYSE American: RGNT) was featured in a recent article that discussed its efforts to advance GelrinC, a potentially first-in-class, off-the-shelf cartilage regeneration platform, and the company’s broader mission to establish a new standard of care in cartilage repair. “Regentis is developing regenerative biomaterial technology as healthcare shifts toward therapies designed to restore damaged tissue rather than simply manage symptoms.


Quantum BioPharma (QNTM) Advances MS Imaging Study With Encouraging Preliminary Results

August 3, 2026LOS ANGELES, CA - August 3, 2026 (NEWMEDIAWIRE) - Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) has reached the halfway point in patient enrollment for its pilot MS imaging study with Massachusetts General Hospital, with preliminary PET imaging data showing encouraging signals in acute MS lesions. The novel imaging technique is designed to distinguish demyelinated nerve fibers that may still be viable from permanent nerve damage, potentially offering a more precise way to measure myelin loss and repair.


Gold, Critical Minerals, Hydrogen, and AI: Companies Present at the August 5-6 OTCQB Virtual Investor Conference

August 3, 2026Gold Camps, Hydrogen Wells, AI Agents, and Clinical Pipelines on One Venture Market Meet With Management Teams From OTCQB Venture Market Companies, Many Dual-Listed on the ASX, TSX, TSX Venture Exchange, CSE, and AQSE NEW YORK, NY - August 3, 2026 (NEWMEDIAWIRE) - B2i Digital, Inc. invites investors to its latest Featured Conference: the OTCQB Virtual Investor Conference, taking place Wednesday and Thursday, August 5-6, 2026.


GeoVax Highlights Newly Published Independent Research Supporting Broader Filovirus Vaccine Strategies and Strategic Value of Its MVA-Based Vaccine Portfolio

August 3, 2026Recent Third-Party Research Reinforces Scientific Rationale for Evaluating Broad-Spectrum Filovirus Preparedness Approaches ATLANTA, GA - August 3, 2026 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing vaccines and immunotherapies for infectious diseases and solid tumors, today highlighted recently published independent scientific research that reinforces growing interest in vaccine strategies capable of providing broader protection across multiple ebolavirus species.